NCEC and OURAY Announce Integrated Emergency Response Support for the Global Market
NCEC, the chemical experts arm of the Ricardo Group, is partnering with OURAY, a global environmental, engineering, manufacturing, and chemical services company, to offer Level One emergency response to OURAY customers, with an emphasis on the Americas and Asia-Pacific regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005770/en/
The National Chemical Emergency Centre (NCEC) (Photo: Business Wire)
OURAY’s customers will receive vital telephone-based advice from the experienced NCEC team in the event of a chemical emergency.
The agreement underpins the APAC Emergency Response initiative, which is due to start in January from OURAY’s new Singapore base, to provide a chemical response service for the Asia-Pacific region. The telephone emergency response (Level 1) will be carried out by NCEC’s best-in-class emergency response service. The on-site expert advice (Level 2) and the on-ground responder (Level 3) service will be provided by OURAY.
Jon Gibbard, Director of NCEC, said: “We have an experienced team of responders who are able to ask appropriate questions to understand the context of the scene, and alongside other sources of information such as SDSs, Chemdata and the responders’ own knowledge, they are able to give proportionate, actionable advice to the caller at the scene of the incident.”
Aaron Montgomery, CHMM/OURAY President and CEO, said: “OURAY is extremely excited about offering these combined services to the marketplace. This OURAY/NCEC partnership will allow our organisations to be the first in the world to provide combined Level 1, 2 and 3 services. This signifies a large step forward in OURAY’s mission to be a complete turn-key solution to the global chemical supply chain.”
Mr Gibbard said: “It is a great opportunity for NCEC/OURAY to support customers with best-in-class emergency response services within the Americas and Asia-Pacific region. We are excited to be working with OURAY. This holistic approach to emergency response further supports our vision to create a world fit for the future by reducing harm from incidents globally. This partnership is a clear indication of how NCEC’s advice-focused approach to emergency response is valued within the market. We are all looking forward to getting started.”
Information for editors
About NCEC
NCEC, part of Ricardo, is a leading provider of chemical emergency response and chemical regulatory support services, enabling customers to reduce the impact their activities have on people and the environment, while protecting their reputation and assets. Offering telephone emergency response, regulatory compliance and policy consultation and hazardous material (hazmat) training, NCEC is the first choice for some of the largest chemical companies across the globe. For more information, visit https://the-ncec.com/
About OURAY
OURAY is a leading and global environmental, engineering, manufacturing and chemical services company, offering solutions in over 100 countries. OURAY helps clients reach their long-term goals, by utilising its knowledge and experience across their global network to assist them with their most pressing needs.
https://www.OURAYservices.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005770/en/
Contact information
Julie Palmer
Marketing and Communications, Ricardo Energy & Environment
Tel: 01235 753467
Email: Julie.palmer@ricardo.com
Gill Gibbons
Ricardo Media Office
Tel: +44 (0)7795 342804
E-mail: media@ricardo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release
Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom